Per Stirling Capital Management, Llc. Abb Vie Inc. Transaction History
Per Stirling Capital Management, Llc.
- $621 Billion
- Q2 2024
A detailed history of Per Stirling Capital Management, Llc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Per Stirling Capital Management, Llc. holds 9,903 shares of ABBV stock, worth $2 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
9,903
Previous 4,369
126.67%
Holding current value
$2 Million
Previous $796 Million
113.52%
% of portfolio
0.27%
Previous 0.13%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
3,760Shares Held
1.28BCall Options Held
13MPut Options Held
9.83M-
Vanguard Group Inc Valley Forge, PA171MShares$34.4 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.7 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.8 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.78 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $356B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...